公司资料

Fonar 股价、新闻与催化剂

股票代码:
FONR
交易所:
NASDAQ
行业:
Biopharma
所在地:
United States

股票表现

19.09 USD (-0.10%)

收盘价

最后更新: 2026年6月2日

120M USD

市值

股价为何变动

目前无法获取 FONR 的收盘价变动背景。

公司概览

业务概览

FONAR is a medical imaging company focused on MRI systems and related diagnostic equipment. Its business centers on imaging technology rather than biotech or therapeutics.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, FONAR sits in medical imaging devices.

商业模式特征

The company depends on equipment demand, imaging utilization, and the performance of its MRI platform.

生物医药行业定位

FONAR is outside biotech and belongs to the imaging-device layer of healthcare.

未来催化剂

  • Fonar’s catalysts are MRI-system demand and recurring-service execution. This is a steady hardware / imaging business, so the market cares about utilization and service revenue.

近期新闻

新闻标题由机器翻译,详情为英文原文。

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

相似股票

商业成熟度、治疗领域或催化剂模式相近的同行公司。